Galactosylhydroxylysine (hydrochloride)
Galactosylhydroxylysine hydrochloride is a component of bone collagen produced by post-translational glycosylation of hydroxylysine. Galactosylhydroxylysine hydrochloride is released during bone resorption and has been shown to be elevated in metabolic bone loss[1].
Product Specifications
UNSPSC
12352005
Target
Endogenous Metabolite
Type
Natural Products
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/galactosylhydroxylysine-hydrochloride.html
Purity
99.90
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
N[C@@H](CCC(O[C@H]1[C@@H]([C@H]([C@H]([C@@H](CO)O1)O)O)O)CN)C(O)=O.[H]Cl
Molecular Formula
C12H25ClN2O8
Molecular Weight
360.79
References & Citations
[1]Leigh SD, et al. Development of an immunoassay for urinary galactosylhydroxylysine. J Immunol Methods. 1998;220 (1-2) :169-178.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, protect from light, stored under nitrogen)
Scientific Category
Natural Products
Clinical Information
No Development Reported
Isoform
Human Endogenous Metabolite
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Lentiviral human NDP shRNA (UAS) - Lentiviral human NDP shRNA (UAS, GFP) (25)
